FARALLON CAPITAL MANAGEMENT, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000909661

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Tom Steyer — tracked via quarterly SEC 13F filings · All famous investors

LargeHealth TiltHigh Turnover how tags are computed

Q2 2026 · 89 positions · Total reported value $22.91B · Top-10 concentration 59.4% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.4% · 43 new · 19 cut · 23 exited

Active Share (vs S&P 500): 91.2% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 89 equity positions with a combined reported value of $22.91B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.4% of reported value. HoldingsHub classifies the profile as Large / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were SPY ($4.48B), RVMD ($2.54B), EA ($1.62B). By sector, the heaviest allocations are Health Care 48.2%, Technology 6.3%. Versus the prior quarter, allocation shifted toward Other (+17.9pp), Health Care (+4.7pp) and away from Communication Services (-0.9pp), Industrials (-1.3pp).

Versus the prior quarter, FARALLON CAPITAL MANAGEMENT, L.L.C. opened 43 new positions, trimmed 19 and fully exited 23, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 35% of names.

The largest new positions opened in Q2 2026 were SPY ($4.48B), APGE ($140.69M), SOXX ($83.30M).

Of the 23 positions fully exited versus the prior quarter, the largest were SCHW ($371.75M), GOOG ($285.78M), V ($254.10M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • SPY STATE STR SPDR S&P 500 ETF T · $4.48B
  • APGE APOGEE THERAPEUTICS INC · $140.69M
  • SOXX ISHARES TR · $83.30M
  • PBLS PARABILIS MEDICINES INC · $64.82M
  • NVS NOVARTIS AG · $56.89M
  • WRBY WARBY PARKER INC · $25.12M
  • KLRA KAILERA THERAPEUTICS INC · $24.23M
  • AXTA AXALTA COATING SYS LTD · $16.36M

Fully Exited (vs previous quarter)

  • SCHW CHARLES SCHWAB CORP (THE) · prev qtr: $371.75M
  • GOOG ALPHABET INC · prev qtr: $285.78M
  • V VISA INC · prev qtr: $254.10M
  • DIS DISNEY WALT CO · prev qtr: $231.47M
  • MA MASTERCARD INCORPORATED · prev qtr: $217.39M
  • MCK MCKESSON CORP · prev qtr: $202.75M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $191.01M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $137.15M

Insider Transactions (Form 4)

Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Farallon Capital Management is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 86 US equity positions with a combined value of $21.54B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-51763 (status: Approved), registered 1996-04-01
  • Regulatory AUM (Form ADV): $52.08B as of 2026-09-23
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 50 private funds, of which 50 hedge funds
  • Website: faralloncapital.com

Portfolio Structure

  • 86 positions · $21.54B reported value (Q2 2026)
  • Top 10 holdings = 62.5% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 20.8%
  • Average position size: $250.46M

Sector Tilt

  • Health Care 51.2%
  • Information Technology 6.7%
  • Consumer Discretionary 4.0%
  • (classified holdings cover 70% of value)

Quarterly Activity

  • Q2 2026: 20 new, 29 added, 23 reduced, 103 exited
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Farallon increased passive exposure (SPY new) and selectively added/reduced biotech/healthcare names, suggesting a bullish market view with tactical bets on high-growth sectors. 2. Key moves: - Added: SPY (20.80% new), EA (+6.0%), BBIO (+14.7%), EXEL (+2.7%). - Reduced: AMZN (-37.6%), NTRA (-30.8%), LQDA (-3.4%). - Held: RVMD, PTGX, LNTH. 3. Portfolio structure: Dominated by active healthcare (70% of top-10) with a large passive (SPY) anchor; moderate risk appetite via concentrated biotech bets. 4. Per-holding one-liner: - SPY: S&P 500 ETF (verified). - RVMD: Cancer-focused biotech (verified). - EA: Video game publisher (verified). - BBIO: Gene therapy biotech (verified). - PTGX: Peptide drug developer (verified). - EXEL: Oncology-focused biotech (verified). - LQDA: Drug delivery biotech (verified). - AMZN: E-commerce/cloud giant (verified). - LNTH: Neuroimaging biotech (verified). - NTRA: Non-invasive prenatal testing (verified). 5. Style summary: Bullish on equities with a tilted healthcare focus, blending passive exposure with active biotech trades.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 48.2%
Technology 6.3%
Financials 3.7%
Materials 0.1%
Other 29.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.00M $4.48B 19.56%
19.56%
New
2 13.55M $2.54B 11.08%
11.08%
Hold
3 7.92M $1.62B 7.09%
7.09%
Add
4 10.74M $800.14M 3.49%
3.49%
Add
5 6.35M $778.25M 3.40%
3.40%
Hold
6 28.10M $749.15M 3.27%
3.27%
Add
7 13.47M $732.79M 3.20%
3.20%
Add
8 8.37M $666.94M 2.91%
2.91%
Reduce
9 2.63M $627.55M 2.74%
2.74%
Reduce
10 5.58M $619.43M 2.70%
2.70%
Hold
11 2.22M $602.18M 2.63%
2.63%
Reduce
12 1.27M $528.07M 2.31%
2.31%
Reduce
13 1.05M $526.02M 2.30%
2.30%
Add
14 14.31M $506.40M 2.21%
2.21%
Add
15 25.02M $478.04M 2.09%
2.09%
Reduce
16 1.38M $458.58M 2.00%
2.00%
Reduce
17 10.52M $449.04M 1.96%
1.96%
Add
18 1.15M $435.09M 1.90%
1.90%
Reduce
19 1.11M $415.12M 1.81%
1.81%
Reduce
20 12.28M $383.78M 1.68%
1.68%
Add
21 4.12M $377.98M 1.65%
1.65%
Reduce
22 829.60K $370.06M 1.61%
1.61%
Reduce
23 10.24M $351.31M 1.53%
1.53%
Add
24 8.99M $336.37M 1.47%
1.47%
Add
25 4.16M $284.11M 1.24%
1.24%
Add
26 894.50K $241.16M 1.05%
1.05%
Reduce
27 5.80M $223.67M 0.98%
0.98%
Add
28 2.14M $219.79M 0.96%
0.96%
Add
29 5.92M $219.59M 0.96%
0.96%
Add
30 3.63M $206.30M 0.90%
0.90%
Reduce
31 1.06M $140.69M 0.61%
0.61%
New
32 1.20M $137.58M 0.60%
0.60%
Add
33 2.62M $125.55M 0.55%
0.55%
Add
34 4.22M $124.64M 0.54%
0.54%
Add
35 1.73M $120.85M 0.53%
0.53%
Add
36 574.00K $108.84M 0.47%
0.47%
Add
37 408.00K $103.62M 0.45%
0.45%
Add
38 130.00K $83.30M 0.36%
0.36%
New
39 2.37M $64.82M 0.28%
0.28%
New
40 363.00K $56.89M 0.25%
0.25%
New
41 322.20K $48.34M 0.21%
0.21%
Add
42 2.50M $46.16M 0.20%
0.20%
Add
43 699.20K $46.14M 0.20%
0.20%
Add
44 1.60M $44.09M 0.19%
0.19%
Add
45 2.42M $35.26M 0.15%
0.15%
Reduce
46 1.11M $33.06M 0.14%
0.14%
Add
47 400.00K $28.42M 0.12%
0.12%
Add
48 199.00K $25.57M 0.11%
0.11%
Reduce
49 828.00K $25.12M 0.11%
0.11%
New
50 2.25M $24.48M 0.11%
0.11%
Hold

FAQ

What did FARALLON CAPITAL MANAGEMENT, L.L.C. buy in 2026-Q2?

In its 2026-Q2 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. reported 89 equity positions worth $22.91B in aggregate; its largest disclosed positions were SPY ($4.48B), RVMD ($2.54B), EA ($1.62B).

How large is FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio?

FARALLON CAPITAL MANAGEMENT, L.L.C. reported $22.91B of long equity holdings across 89 positions as of 2026-Q2. Top-10 holdings account for 59.4% of reported value.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Large / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/farallon-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →